Oncology Diagnostics: Global Markets

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Highlights of the Market for Oncology Diagnostics

Chapter 3 Medical Device Regulations

Medical Device Definition and Classification
Regulations in the U.S.

• Legislation

Regulations in Europe

• Process

Regulations in Japan

Chapter 4 Oncology Diagnostics: Market Background

Introduction
Cancer

• Cancer Cells versus Normal Cells
• Types of Cancer
• Pipeline

Chapter 5 Oncology Diagnostics: Market Dynamics

Market Dynamics

• Drivers
• Market Restraints

Chapter 6 Impact of COVID-19 Pandemic

Introduction
Outbreak
Spread of Disease
Impact on MedTech

• Elective and Noncritical Procedures
• Shift in Manufacturing
• Regulatory Delays, Clinical Trials and Product Launches
• Supply Chain Disruptions
• Medical Tourism

Impact of COVID-19 on the Global Economy
Government Expenditures on COVID-19
Impact on Insurance Providers
Impact of COVID-19 on Oncology

• Impact on Early Cancer Diagnosis
• Impact on Cancer Research
• COVID-19 and Reimagining Cancer Care
• Significant Declines in Testing and Diagnosis
• Public Health Impact of COVID-19 Across the Cancer Continuum

Chapter 7 Market Breakdown by Product Category

Introduction
Diagnostic Imaging

• Market Size and Forecast
• Market Analysis

Endoscopy

• Market Size and Forecast
• Market Analysis

Biopsies

• Market Size and Forecast
• Market Analysis

Immunohistochemistry

• Market Size and Forecast
• Market Analysis

In Situ Hybridization

• Market Size and Forecast
• Market Analysis

Tumor Biomarker Tests

• Market Size and Forecast
• Market Analysis

Others

• Market Size and Forecast
• Market Analysis

Chapter 8 Market Breakdown by Application

Introduction
Breast Cancer

• Market Size and Forecast
• Market Analysis

Lung Cancer

• Market Size and Forecast
• Market Analysis

Colorectal Cancer

• Market Size and Forecast
• Market Analysis

Prostate Cancer

• Market Size and Forecast
• Market Analysis

Liver Cancer

• Market Size and Forecast
• Market Analysis

Other Cancers

• Market Size and Forecast
• Market Analysis

Chapter 9 Market Breakdown by End User

Introduction
Hospitals

• Market Size and Forecast
• Market Analysis

Diagnostic Imaging Centers

• Market Size and Forecast
• Market Analysis

Research Institutes

• Market Size and Forecast
• Market Analysis

Other End Users

• Market Size and Forecast
• Market Analysis

Chapter 10 Market Breakdown by Region

Introduction
North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific

• Japan
• China
• India
• Rest of Asia-Pacific

Rest of the World

Chapter 11 Competitive Landscape

Mergers and Acquisitions
Strategic Alliances

Chapter 12 Company Profiles

ABBOTT
AGILENT TECHNOLOGIES INC.
BIOMERIEUX SA
BIOCARTIS NV
DIASORIN S.P.A.
F. HOFFMANN-LA ROCHE AG
GENERAL ELECTRIC CO.
KONINKLIJKE PHILIPS N.V.
SIEMENS HEALTHCARE GMBH
THERMO FISHER SCIENTIFIC
Chapter 13 Appendix: List of Acronyms

List of Tables

Summary Table A : Global Market for Oncology Diagnostics, by Product Category, Through 2025
Summary Table B : Global Market for Oncology Diagnostics, by Application, Through 2025
Table 1 : Class I and Class II 510(k) Exempt Devices
Table 2 : Cancer Incidence and Mortality Statistics, by Region, 2020
Table 3 : Global Elderly Population (60+ Years), by Country, 2019
Table 4 : Cancer Incidence and Mortality, 65+ Population
Table 5 : Expenditures on COVID-19 Crisis, by Selected Country
Table 6 : Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 7 : Global Market for Oncology Diagnostics, by Product Category, Through 2025
Table 8 : Most Common Types of Endoscopy
Table 9 : Characteristics of In Situ Hybridization Methods
Table 10 : In Situ Hybridization Probe Types
Table 11 : Common Types of Tumor Markers
Table 12 : Global Market for Oncology Diagnostics, by Application, Through 2025
Table 13 : Countries with the Highest Rates of Breast Cancer, 2018
Table 14 : Countries with Highest Incidence of Lung Cancer, 2018
Table 15 : Countries with the Highest Rates of Colorectal Cancer, 2018
Table 16 : Countries with the Highest Rates of Prostate Cancer, 2018
Table 17 : Countries with the Highest Rates of Liver Cancer, 2018
Table 18 : Global Market for Oncology Diagnostics, by End User, Through 2025
Table 19 : Selected Cancer Research Institutes
Table 20 : Selected Cancer Research Funding Sources
Table 21 : Global Market for Oncology Diagnostics, by Region, Through 2025
Table 22 : North American Market for Oncology Diagnostics, by Country, Through 2025
Table 23 : North American Market for Oncology Diagnostics, by Product Category, Through 2025
Table 24 : North American Market for Oncology Diagnostics, by Application, Through 2025
Table 25 : North American Market for Oncology Diagnostics, by End User, Through 2025
Table 26 : New Cancer Cases in the U.S., by Cancer Site, 2021
Table 27 : European Market for Oncology Diagnostics, by Country, Through 2025
Table 28 : European Market for Oncology Diagnostics, by Product Category, Through 2025
Table 29 : European Market for Oncology Diagnostics, by Application, Through 2025
Table 30 : European Market for Oncology Diagnostics, by End User, Through 2025
Table 31 : Asia-Pacific Market for Oncology Diagnostics, by Country, Through 2025
Table 32 : Asia-Pacific Market for Oncology Diagnostics, by Product Category, Through 2025
Table 33 : Asia-Pacific Market for Oncology Diagnostics, by Application, Through 2025
Table 34 : Asia-Pacific Market for Oncology Diagnostics, by End User, Through 2025
Table 35 : RoW Market for Oncology Diagnostics, by Product Category, Through 2025
Table 36 : RoW Market for Oncology Diagnostics, by Application, Through 2025
Table 37 : RoW Market for Oncology Diagnostics, by End User, Through 2025
Table 38 : Leading Causes of Death in Argentina and Percentage Change, 2007-2017
Table 39 : Abbott: Oncology Diagnostics Product Portfolio
Table 40 : Agilent: Oncology Diagnostics Product Portfolio
Table 41 : bioMérieux: Oncology Diagnostics Product Portfolio
Table 42 : Biocartis: Oncology Diagnostics Product Portfolio
Table 43 : DiaSorin Group: Oncology Diagnostics Product Portfolio
Table 44 : Roche: Oncology Diagnostics Product Portfolio
Table 45 : General Electric Co.: Oncology Diagnostics Product Portfolio
Table 46 : Philips: Oncology Diagnostics Product Portfolio
Table 47 : Siemens: Oncology Diagnostics Product Portfolio
Table 48 : Thermo Fisher Scientific: Oncology Diagnostics Product Portfolio
Table 49 : Acronyms Used in the Oncology Diagnostics Industry

List of Figures

Summary Figure A : Global Market for Oncology Diagnostics, by Product Category, 2019-2025
Summary Figure B : Global Market Share of Oncology Diagnostics, by Product Category, 2020
Summary Figure C : Global Market for Oncology Diagnostics, by Application, 2019-2025
Figure 1 : Marketing a Medical Device in the U.S.
Figure 2 : New Cases of the Most Common Types of Cancer, Globally, 2020
Figure 3 : Cancer Prevalence, by Country, 2017-2020
Figure 4 : Countries with the Highest Expected Percentage of People Aged 60+, 2050
Figure 5 : Comparison of GDP Growth, by Country, 2019 and 2020
Figure 6 : Potential Impact of the COVID-19 Pandemic on Future Cancer Outcomes
Figure 7 : Global Market Share for Oncology Diagnostics, by Product Category, 2020
Figure 8 : Global Market for Diagnostic Imaging, 2019-2025
Figure 9 : Global Market for Endoscopy, 2019-2025
Figure 10 : Global Market for Biopsies, 2019-2025
Figure 11 : Global Market for Immunohistochemistry, 2019-2025
Figure 12 : Global Market for In Situ Hybridization, 2019-2025
Figure 13 : Global Market for Tumor Biomarker Tests, 2019-2025
Figure 14 : Global Market for Other Types of Oncology Diagnostic Products, 2019-2025
Figure 15 : Global Market Share for Oncology Diagnostics, by Application, 2020
Figure 16 : Global Market for Breast Cancer Diagnostics for, 2019-2025
Figure 17 : Global Market for Lung Cancer Diagnostics, 2019-2025
Figure 18 : Global Market for Colorectal Cancer Diagnostics, 2019-2025
Figure 19 : Global Market for Prostate Cancer Diagnostics, 2019-2025
Figure 20 : Global Market for Liver Cancer Diagnostics, 2019-2025
Figure 21 : Global Market for Oncology Diagnostics, Other Types of Cancer, 2019-2025
Figure 22 : Global Market for Oncology Diagnostics, by End User, 2020
Figure 23 : Global Market for Oncology Diagnostics in Hospitals, 2019-2025
Figure 24 : Global Market for Oncology Diagnostics in Diagnostic Imaging Centers, 2019-2025
Figure 25 : Global Market for Oncology Diagnostics in Research Institutes, 2019-2025
Figure 26 : Global Market for Oncology Diagnostics for Other End Users, 2019-2025
Figure 27 : Global Market Share for Oncology Diagnostics, by Region, 2020
Figure 28 : North American Market Share for Oncology Diagnostics, by Country, 2020
Figure 29 : The U.S. Market for Oncology Diagnostics, 2019-2025
Figure 30 : Canadian Market for Oncology Diagnostics, 2019-2025
Figure 31 : Number of New Cancer Cases in Canada, by Cancer Site, 2020
Figure 32 : Share of New Cancer Cases in Canada, by Cancer Site, 2020
Figure 33 : European Market Share for Oncology Diagnostics, by Country, 2020
Figure 34 : German Market for Oncology Diagnostics, 2019-2025
Figure 35 : Number of New Cases in Germany, by Cancer Site, 2020
Figure 36 : Share of New Cancer Cases in Germany, by Cancer Site, 2020
Figure 37 : UK Market for Oncology Diagnostics, 2019-2025
Figure 38 : French Market for Oncology Diagnostics, 2019-2025
Figure 39 : Number of New Cancer Cases in France, by Cancer Site, 2020
Figure 40 : Share of New Cancer Cases in France, by Cancer Site, 2020
Figure 41 : Italian Market for Oncology Diagnostics, 2019-2025
Figure 42 : Number of New Cancer Cases in Italy, by Cancer Site, 2020
Figure 43 : Share of New Cancer Cases in Italy, by Cancer Site, 2020
Figure 44 : Spanish Market for Oncology Diagnostics, 2019-2025
Figure 45 : Number of New Cancer Cases in Spain, by Cancer Site, 2020
Figure 46 : Share of New Cancer Cases in Spain, by Cancer Site, 2020
Figure 47 : Rest of European Market for Oncology Diagnostics, 2019-2025
Figure 48 : Asia-Pacific Market Share for Oncology Diagnostics, by Country, 2020
Figure 49 : Japanese Market for Oncology Diagnostics, 2019-2025
Figure 50 : Number of New Cancer Cases in Japan, by Cancer Site, 2020
Figure 51 : Share of New Cancer Cases in Japan, by Cancer Site, 2020
Figure 52 : Chinese Market for Oncology Diagnostics, 2019-2025
Figure 53 : Number of New Cancer Cases in China, by Cancer Site, 2020
Figure 54 : Share of New Cancer Cases in China, by Cancer Site, 2020
Figure 55 : Indian Market for Oncology Diagnostics, 2019-2025
Figure 56 : Number of New Cancer Cases in India, by Cancer Site, 2020
Figure 57 : Share of New Cancer Cases in India, by Cancer Site, 2020
Figure 58 : Rest of Asia-Pacific Market for Oncology Diagnostics, 2019-2025
Figure 59 : Rest of the World Market for Oncology Diagnostics, 2019-2025
Figure 60 : Number of New Cancer Cases in Brazil, by Cancer Site, 2020
Figure 61 : Share of New Cancer Cases in Brazil, by Cancer Site, 2020
Figure 62 : New Cancer Cases in Africa, by Cancer Site, 2020
Figure 63 : New Cancer Cases Share in Africa, by Cancer Site, 2020
Figure 64 : Abbott: Annual Revenue, 2018-2020
Figure 65 : Abbott: Revenue Share, by Country, 2020
Figure 66 : Abbott: Revenue Share, by Business Segment, 2020
Figure 67 : Agilent: Annual Revenue, 2018-2020
Figure 68 : Agilent: Revenue Share, by Region, 2020
Figure 69 : Agilent: Revenue Share, by Segment, 2020
Figure 70 : DiaSorin Group: Annual Revenue, 2018 and 2019
Figure 71 : DiaSorin Group: Revenue Share, by Region/Country, 2019
Figure 72 : Roche: Revenue Share, by Business Segment, 2020
Figure 73 : General Electric Co.: Annual Revenue, 2018-2020
Figure 74 : General Electric Co.: Revenue Share, by Region/Country, 2020
Figure 75 : General Electric Co.: Revenue Share, by Business Segment, 2020
Figure 76 : Philips: Annual Revenue, 2018-2020
Figure 77 : Philips: Revenue Share, by Region/Country, 2020
Figure 78 : Philips: Revenue Share, by Business Segment, 2020
Figure 79 : Siemens: Annual Revenue, 2019 and 2020
Figure 80 : Siemens: Revenue Share, by Business Segment, 2020
Figure 81 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
Figure 82 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020

当レポートのプレスリリースは発行されておりません。